These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
222 related articles for article (PubMed ID: 30992036)
1. Predictors of neutrophil extracellular traps markers in type 2 diabetes mellitus: associations with a prothrombotic state and hypofibrinolysis. Bryk AH; Prior SM; Plens K; Konieczynska M; Hohendorff J; Malecki MT; Butenas S; Undas A Cardiovasc Diabetol; 2019 Apr; 18(1):49. PubMed ID: 30992036 [TBL] [Abstract][Full Text] [Related]
2. Prothrombotic fibrin clot properties associated with increased endogenous thrombin potential and soluble P-selectin predict occult cancer after unprovoked venous thromboembolism. Mrozinska S; Cieslik J; Broniatowska E; Malinowski KP; Undas A J Thromb Haemost; 2019 Nov; 17(11):1912-1922. PubMed ID: 31323706 [TBL] [Abstract][Full Text] [Related]
3. Prothrombotic fibrin clot properties associated with NETs formation characterize acute pulmonary embolism patients with higher mortality risk. Ząbczyk M; Natorska J; Janion-Sadowska A; Metzgier-Gumiela A; Polak M; Plens K; Janion M; Skonieczny G; Mizia-Stec K; Undas A Sci Rep; 2020 Jul; 10(1):11433. PubMed ID: 32651425 [TBL] [Abstract][Full Text] [Related]
4. Hypofibrinolysis in type 2 diabetes and its clinical implications: from mechanisms to pharmacological modulation. Bryk-Wiązania AH; Undas A Cardiovasc Diabetol; 2021 Sep; 20(1):191. PubMed ID: 34551784 [TBL] [Abstract][Full Text] [Related]
5. NETosis in Long-Term Type 1 Diabetes Mellitus and Its Link to Coronary Artery Disease. Aukrust SG; Holte KB; Opstad TB; Seljeflot I; Berg TJ; Helseth R Front Immunol; 2021; 12():799539. PubMed ID: 35069582 [TBL] [Abstract][Full Text] [Related]
6. Markers of NET formation and stroke risk in patients with atrial fibrillation: association with a prothrombotic state. Mołek P; Ząbczyk M; Malinowski KP; Natorska J; Undas A Thromb Res; 2022 May; 213():1-7. PubMed ID: 35276507 [TBL] [Abstract][Full Text] [Related]
7. Neutrophil extracellular traps in patients with liver cirrhosis and hepatocellular carcinoma. Zenlander R; Havervall S; Magnusson M; Engstrand J; Ågren A; Thålin C; Stål P Sci Rep; 2021 Sep; 11(1):18025. PubMed ID: 34504150 [TBL] [Abstract][Full Text] [Related]
8. Citrullinated histone H3, a biomarker for neutrophil extracellular trap formation, predicts the risk of mortality in patients with cancer. Grilz E; Mauracher LM; Posch F; Königsbrügge O; Zöchbauer-Müller S; Marosi C; Lang I; Pabinger I; Ay C Br J Haematol; 2019 Jul; 186(2):311-320. PubMed ID: 30968400 [TBL] [Abstract][Full Text] [Related]
9. Enhanced neutrophil extracellular traps formation in AF patients with dilated left atrium. Mołek P; Ząbczyk M; Malinowski KP; Natorska J; Undas A Eur J Clin Invest; 2023 May; 53(5):e13952. PubMed ID: 36635213 [TBL] [Abstract][Full Text] [Related]
10. The association between circulating neutrophil extracellular trap related biomarkers and retinal vein occlusion incidence: A case-control pilot study. Wan W; Liu H; Long Y; Wan W; Li Q; Zhu W; Wu Y Exp Eye Res; 2021 Sep; 210():108702. PubMed ID: 34270977 [TBL] [Abstract][Full Text] [Related]
11. High-dose atorvastatin and rosuvastatin reduce the levels of neutrophil extracellular trap-related proteins in coronary artery disease: association with prothrombotic state. Stępień K; Natorska J; Ząbczyk M; Zalewski J; Jawień J; Undas A Pol Arch Intern Med; 2024 Oct; 134(10):. PubMed ID: 39324258 [TBL] [Abstract][Full Text] [Related]
12. Markers of neutrophil activation and extracellular traps formation are predictive of appendicitis in mice and humans: a pilot study. Boettcher M; Esser M; Trah J; Klohs S; Mokhaberi N; Wenskus J; Trochimiuk M; Appl B; Reinshagen K; Raluy LP; Klinke M Sci Rep; 2020 Oct; 10(1):18240. PubMed ID: 33106536 [TBL] [Abstract][Full Text] [Related]
13. Prolonged duration of type 2 diabetes is associated with increased thrombin generation, prothrombotic fibrin clot phenotype and impaired fibrinolysis. Konieczynska M; Fil K; Bazanek M; Undas A Thromb Haemost; 2014 Apr; 111(4):685-93. PubMed ID: 24306139 [TBL] [Abstract][Full Text] [Related]
14. Citrullinated histone H3, a biomarker of neutrophil extracellular trap formation, predicts the risk of venous thromboembolism in cancer patients. Mauracher LM; Posch F; Martinod K; Grilz E; Däullary T; Hell L; Brostjan C; Zielinski C; Ay C; Wagner DD; Pabinger I; Thaler J J Thromb Haemost; 2018 Mar; 16(3):508-518. PubMed ID: 29325226 [TBL] [Abstract][Full Text] [Related]
15. Plasma Protein Oxidation as a Determinant of Impaired Fibrinolysis in Type 2 Diabetes. Bryk AH; Konieczynska M; Rostoff P; Broniatowska E; Hohendorff J; Malecki MT; Undas A Thromb Haemost; 2019 Feb; 119(2):213-222. PubMed ID: 30605917 [TBL] [Abstract][Full Text] [Related]
16. Hemodynamic force triggers rapid NETosis within sterile thrombotic occlusions. Yu X; Tan J; Diamond SL J Thromb Haemost; 2018 Feb; 16(2):316-329. PubMed ID: 29156107 [TBL] [Abstract][Full Text] [Related]
17. Cell-Free DNA Modulates Clot Structure and Impairs Fibrinolysis in Sepsis. Gould TJ; Vu TT; Stafford AR; Dwivedi DJ; Kim PY; Fox-Robichaud AE; Weitz JI; Liaw PC Arterioscler Thromb Vasc Biol; 2015 Dec; 35(12):2544-53. PubMed ID: 26494232 [TBL] [Abstract][Full Text] [Related]
18. Citrullinated histone H3 as a novel prognostic blood marker in patients with advanced cancer. Thålin C; Lundström S; Seignez C; Daleskog M; Lundström A; Henriksson P; Helleday T; Phillipson M; Wallén H; Demers M PLoS One; 2018; 13(1):e0191231. PubMed ID: 29324871 [TBL] [Abstract][Full Text] [Related]
19. Neutrophil-activating Peptide 2 as a Novel Modulator of Fibrin Clot Properties in Patients with Atrial Fibrillation. Ząbczyk M; Natorska J; Matusik PT; Mołek P; Wojciechowska W; Rajzer M; Rajtar-Salwa R; Tokarek T; Lenart-Migdalska A; Olszowska M; Undas A Transl Stroke Res; 2024 Aug; 15(4):773-783. PubMed ID: 37294500 [TBL] [Abstract][Full Text] [Related]